General Information of the Compound
Compound ID |
CP0040158
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
7,4′-Dihydroxy-isoflavone (3a)
Show/Hide
|
||||||||||||||||||
Synonyms |
,7-Dihydroxyisoflavone
4',7-Dihydroxy-iso-flavone
4',7-Dihydroxyisoflavone
4,7-Dihydroxyisoflavone
486-66-8
4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-
7,4'-Dihydroxyisoflavone
7,4'-dihydroxyisoflavone
7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone
7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one
7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one
BRN 0231523
CCRIS 7600
CHEMBL8145
DIADZEIN
Daidzein
Daidzeol
EINECS 207-635-4
K 251b
UNII-6287WC5J2L
d-(+)-alpha-methylbenzylamine
daidzein
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C15H10O4
|
||||||||||||||||||
Molecular Weight |
254.241
|
||||||||||||||||||
Canonical SMILES |
Oc1ccc(cc1)-c1coc2cc(O)ccc2c1=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C15H10O4/c16-10-3-1-9(2-4-10)13-8-19-14-7-11(17)5-6-12(14)15(13)18/h1-8,16-17H
Show/Hide
|
||||||||||||||||||
InChIKey |
ZQSIJRDFPHDXIC-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
486-66-8
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( daidzein )
Drug Name | daidzein | ||
---|---|---|---|
Target(s) |